Nabla, a clinical AI company, has appointed Brian Manning as chief executive officer. Manning brings over 20 years of experience scaling technology businesses and building commercial teams. Most recently, Manning served as president and chief revenue officer of Bamboo Health, where he helped scale the company to more than $140 million in annual recurring revenue. He previously worked at PatientPing and Zocdoc. Manning joins as Nabla supports more than 190 healthcare organisations, 100,000 clinicians, and 40 million patient encounters annually. The platform is deployed across health systems including CVS Health, UCLA Health, and University of Iowa Health Care. Alex LeBrun, Nabla's co-founder and former chief executive, will continue as executive chairman and chief AI officer, leading the company's AI strategy and product vision.

Nabla names former Bamboo Health Executive Brian Manning as CEO to accelerate enterprise growth. What you should know. * Ambient clinical AI pioneer Nabla has appointed Brian Manning as Chief Executive Officer to scale its enterprise go-to-market execution and global expansion. * Manning previously served as President and CRO at Bamboo Health (scaling ARR to $140M+), led GTM strategy at PatientPing through its acquisition, and helped launch the enterprise sales engine at Zocdoc. * Co-founder and former CEO Alex LeBrun moves to Executive Chairman and Chief AI Officer, focusing strictly on Nabla's AI strategy, model development, and frontier research. Pairing commercial scale with frontier AI research. Brian Manning brings over two decades of experience expanding healthtech platforms. Most recently as President and CRO of Bamboo Health, he scaled the organization past $140 million in annual recurring revenue (ARR) and 300 employees. His background also includes building PatientPing's GTM engine from early-stage through its successful acquisition, alongside launching enterprise sales at Zocdoc. "Brian is the right leader to help Nabla build on the exceptional foundation our team has created," said Alex LeBrun, Executive Chairman and Chief AI Officer at Nabla. "Brian has a rare ability to build organizations that pair commercial excellence with long-term vision. As healthcare enters a new era of AI, that combination is exactly what's needed to extend Nabla's leadership as we build the clinical AI layer for modern healthcare." Manning joins a founding leadership team - including COO Delphine Groll, CTO Martin Raison, and CPO Laurent Landowski - that has built immense commercial momentum: * Clinicians Supported Nationwide: 100,000+ Clinicians * Healthcare Systems Deployed: 190+ Health Systems * Annual Patient Encounters Handled: 40 Million Encounters * Multilingual Support Capabilities: 35+ Languages Supported Former CEO Alex LeBrun will now focus exclusively on advancing Nabla's technological moat as Chief AI Officer. LeBrun also serves as CEO of AMI Labs, a frontier AI research company founded alongside Turing Award winner and Meta's former Chief AI Scientist, Yann LeCun. Having secured over $1.2 billion in research capital, AMI Labs maintains an exclusive partnership with Nabla - giving Nabla direct, early access to breakthrough "world models" designed to transform clinical intelligence. "What attracted me to Nabla is the combination of its outstanding team, crucial mission, product excellence, and customer obsession," noted Manning. "The opportunity now is to accelerate that momentum, expand our reach, and further establish Nabla as the clinical AI partner of choice for healthcare organizations across the world."

University of Toledo Health has partnered with Nabla to deploy AI-powered clinical documentation across hundreds of physicians and advanced practice providers. The academic health system selected Nabla after evaluating multiple AI documentation assistants for its technical performance and collaborative approach. During an eight-week evaluation, clinicians using Nabla reduced time to chart closure by 29%, whilst documentation backlogs in several departments dropped from over 400 open charts to fewer than 30. The system also observed improvements in documentation completeness and coding specificity, supporting more accurate capture of higher-acuity visits and strengthening revenue cycle performance. Nabla integrates directly with Epic, enabling clinicians across multiple specialties to generate structured documentation within existing workflows. The company has raised $120 million and is used across more than 150 health systems and provider groups.